Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / CD Molecules

Recombinant Human CD200 Protein, N-His

Catalog #:   YHE30301 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P41217
Protein length: Gln31-Gly232
Overview

Catalog No.

YHE30301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Gln31-Gly232

Predicted molecular weight

24.76 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P41217

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

OX-2 membrane glycoprotein, MOX2, MOX1, CD200

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CD200
References

CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth., PMID:40461553

Mapping Inherited Genetic Variation with Opposite Effects on Autoimmune Disease and Four Cancer Types Identifies Candidate Drug Targets Associated with the Anti-Tumor Immune Response., PMID:40428397

Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations., PMID:40389402

CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases., PMID:40307896

Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantation., PMID:40251154

Regulation mechanism of chemokine CXCL3 in nasopharyngeal carcinoma., PMID:40239601

Low Intratumoral CD200 Protein Expression in Primary Merkel Cell Carcinoma Is a Strong Predictor for Disease Relapse., PMID:40075669

Monocytes from patients with myelodysplastic syndrome inhibit natural killer cell-mediated antitumor function through the CD200/CD200R pathway., PMID:40049088

Effects of Oral Administration of the Probiotic Lactobacillus rhamnosus GG on the Proteomic Profiles of Cerebrospinal Fluid and Immunoregulatory Signaling in the Hippocampus of Adult Male Rats., PMID:40031897

Polymorphisms in immunosuppression-related genes are associated with AML., PMID:39975548

Targeting CD200 in Breast Cancer: Opportunities and Challenges in Immunotherapeutic Strategies., PMID:39795972

Bone marrow niches orchestrate stem-cell hierarchy and immune tolerance., PMID:39743593

First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid Malignancies., PMID:39651931

Ageing-related changes in the regulation of microglia and their interaction with neurons., PMID:39617175

Exosomes derived from Umbilical cord mesenchymal stem cell promote hair regrowth in C57BL6 mice through upregulation of the RAS/ERK signaling pathway., PMID:39513036

Leukemic B cells expression of CD200 and Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1, CD305) in Chronic Lymphocytic Leukemia patients in relation to Treg frequency., PMID:39471525

Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant., PMID:39450167

Description and functional validation of human enteroendocrine cell sensors., PMID:39418382

CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibody., PMID:39402718

CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection., PMID:39314283

Characterisation of cells markers associated with IKZF1plus in BCP-ALL., PMID:39312877

A squalene oil emulsified MPL-A and anti-CD200/CD300a antibodies adjuvanted whole-killed Leishmania vaccine provides durable immunity against L. donovani parasites., PMID:39288578

Apoptosis Regulation in Dental Pulp Cells and PD-1/PD-L1 Expression Dynamics Under Ozone Exposure - A Pilot Approach., PMID:39277882

Endothelial Cell-Derived Soluble CD200 Determines the Ability of Immune Cells to Cross the Blood-Brain Barrier., PMID:39273210

Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias., PMID:39196193

Differences in immunological profile in atopic dermatitis patients with and without dupilumab therapy., PMID:39148480

Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment., PMID:39120585

Impaired Epithelial CD200L Tolerance Signaling in Irritable Bowel Syndrome Cases With Diarrhea May Be Associated With Recurrent Miscarriages., PMID:39113660

Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies., PMID:39074963

The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming., PMID:39062566

[FAPI-PET-CT for quantification of the tissue response in rheumatic diseases]., PMID:39031195

Immunophenotypic Profile and Measurable Residual Disease Monitoring in Multiple Myeloma: A Prospective Study From a Tertiary Care Centre in Southern India., PMID:38952609

In Silico Exploration of CD200 as a Therapeutic Target for COVID-19., PMID:38930566

Interleukin-6 Signaling Blockade Induces Regulatory Plasmablasts in Neuromyelitis Optica Spectrum Disorder., PMID:38889374

CD200R activation on naïve T cells by B cells induces suppressive activity of T cells via IL-24., PMID:38780647

Molecular incompatibility between pig CD200 and human CD200 receptor in in vitro xenogeneic immune responses., PMID:38751087

Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model., PMID:38745652

Bioinformatic analysis of the role of immune checkpoint genes and immune infiltration in the pathogenesis and development of premature ovarian insufficiency., PMID:38695984

CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival., PMID:38619621

DNA methylation of microRNA-365-1 induces apoptosis of hair follicle stem cells by targeting DAP3., PMID:38616861

The association between expression of CD200 on B lymphocytes and the count of eosinophils and basophils in atopic dermatitis patients with and without dupilumab therapy - Pilot study., PMID:38603859

[IL-1β inhibits macrophage M2 polarization by down-regulating CD200 expression in human umbilical cord mesenchymal stem cells]., PMID:38512028

Dandruff lesional scalp skin exhibits epidermal T cell infiltration and a weakened hair follicle immune privilege., PMID:38488328

JAM3: A prognostic biomarker for bladder cancer via epithelial-mesenchymal transition regulation., PMID:38400838

CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis., PMID:38396288

Inflammatory dendritic cells restrain CD11b+CD4+ CTLs via CD200R in human NSCLC., PMID:38354085

CD200Rhigh neutrophils with dysfunctional autophagy establish systemic immunosuppression by increasing regulatory T cells., PMID:38311677

The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy., PMID:38263709

Expression of Elafin and CD200 as Immune Checkpoint Molecules Involved in Celiac Disease., PMID:38255930

Activation of the CD200/CD200R1 axis improves cognitive impairment by enhancing hippocampal neurogenesis via suppression of M1 microglial polarization and neuroinflammation in hypoxic-ischemic neonatal rats., PMID:38237226

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CD200 Protein, N-His [YHE30301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only